Registro:

Referencias:

• Bots, M.L., Evans, G.W., Riley, W., McBride, K.H., Paskett, E.D., Helmond, F.A., Grobbee, D.E., The effect of tibolone and continuous combined conjugated equine estrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: The Osteoporosis Prevention and Arterial effects of tibolone (OPAL) study (2006) Eur Heart J, 27, pp. 746-755
• Campisi, R., Di Carli, M.F., Assessment of coronary flow reserve and microcirculation: A clinical perspective (2004) J Nucl Cardiol, 1, pp. 3-11
• Campisi, R., Nathan, L., Hernandez-Pampaloni, M., Schöder, H., Sayre, J.W., Chaudhuri, G., Schelbert, H.R., Noninvasive assessment of coronary microcirculatory function in postmenopausal women and of effects of acute and chronic estrogen administration (2002) Circulation, 105, pp. 425-430
• Campisi, R., Camilletti, J., Mele, A., Erriest, J., Pedroni, P., Guiglioni, A., Tibolone improves myocardial perfusion in postmenopausal women with ischemic heart disease: An open-label exploratory pilot study. (2006) J Am Coll Cardiol, 47, pp. 559-564
• Castelo-Branco, C., García-Fantini, M., Haya, J., Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment: Open prospective study with Doppler ultrasonography in internal carotid artery (2005) Maturitas, 50, pp. 259-265
• Cermak, J., Key, N.S., Bach, R.R., Balla, J., Jacob, H.S., Vercellotti, G.M., C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor (1993) Blood, 82, pp. 513-520
• Cicinelli, E., Ignarro, L.J., Galantino, P., Pinto, V., Barba, B., Schonauer, S., Effects of tibolone on plasma levels of nitric oxide in postmenopausal women (2002) Fertil Steril, 78, pp. 464-468
• Cicinelli, E., Ranieri, G., Maffei, S., Colafiglio, G., Ria, R., Bellavia, M., Schonauer, M.M., Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women (2006) Fertil Steril, 86, pp. 899-904
• Clarkson, T.B., Does tibolone exacerbate atherosclerosis? (2006) Eur Heart J, 27, pp. 635-637
• Clarkson, T.B., Anthony, M.S., Cline, J.M., Lees, C.Z., Ederveen, A.G.H., Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys (2004) Maturitas, 48 (1), pp. S24-S29
• De Gooyer, M.E., Deckers, G.H., Wgej, S., Verheul, H.A.M., Kloosterboer, H.J., Receptor profiling and endocrine interactions of tibolone (2003) Steroids, 68, pp. 21-30
• De Kleijn, M.J., Wilmink, H.W., Bots, M.L., Bak, A.A., Van Der Schouw, Y.T., Planellas, J., Engelen, S., Grobee, D.E., Hormone replacement therapy and endothelial function: Results of a randomized controlled trial in healthy postmenopausal women (2001) Atherosclerosis, 159, pp. 357-365
• Duvernoy, C., Martin, J., Briesmiester, K., Bargardi, A., Muzik, O., Mosca, L., Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease (2004) J Clin Endocrinol Metab, 89, pp. 2783-2788
• Eilertsen, A.L., Qvigstad, E., Andersen, T.O., Sandvik, L., Sandset, P.M., Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation (2006) Maturitas, 55, pp. 278-287
• Erenus, M., Ilhan, A.H., Elter, K., Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries (2003) Fertil Steril, 79, pp. 268-273
• Espeland, M.A., Applegate, W., Furberg, C.D., Lefkowitz, D., Rice, L., Hunninghake, D., Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women (1995) Am J Epidemiol, 142, pp. 1011-1019
• Furchgott, R.F., Zawadski, J.V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine (1980) Nature, 288, pp. 373-376
• Garnero, P., Jamin, C., Benhamou, C.L., Pelissier, C., Roux, C., Effects of tibolone and combined 17 beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: A randomized-trial (2002) Hum Reprod, 17, pp. 2748-2753
• Gilligan, D., Quyyumi, A., Cannon, R., Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women (1994) Circulation, 89, pp. 2545-2551
• Gimbrone Jr., M.A., Vascular endothelium: An integrator of pathophysiologyc stimuli in atherosclerosis (1995) Am J Cardiol, 75, pp. 67B-70B
• Haenggi, W., Linder, H.R., Birkhäuser, M.H., Schneider, H., Microscopic findings of the nail-fold capillaries: Dependence on menopausal status and hormone replacement therapy (1998) Maturitas, 22, pp. 37-46
• Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furber, C.D., Al, E., Effects of estrogen replacement on the progression of coronary-artery atherosclerosis (2000) N Engl J Med, 343, pp. 522-529
• Hodis, H.N., MacK, W.J., Lobo, R.A., Shoupe, D., Sevanian, A., Mahrer, P.R., Selzer, R.H., Azen, S.P., Estrogen in the prevention of atherosclerosis (2001) Ann Intern Med, 135, pp. 939-953
• Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., Vittinghoff, E., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group (1998) JAMA, 280, pp. 605-613
• Hulot, J.-S., Démolis, J.-L., Rivière, R., Strabach, S., Christin-Maitre, S., Funck-Brentano, C., Influence of endogenous oestrogens on QT interval duration (2003) Eur Heart J, 24, pp. 1663-1667
• Jackson, G., Tibolone and the cardiovascular system (2001) Eur Heart J Supplements, 3, pp. M17-M21
• Kaleli, B., Yldirim, B., Demir, S., Alatas, E., Effects of low-dose 17-β-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women (2003) Acta Obstet Gynecol Scand, 82, pp. 1107-1111
• Kenemans, P., Tibolone: How does its mechanism of action translate into clinical effects (2004) Maturitas, 48 (1), pp. S1-S3
• Kenemans, P., Speroff, L., Tibolone: Clinical recommendations and practical guidelines: A report of the International Tibolone Consensus Group (2005) Maturitas, 51, pp. 21-28
• Kloosterboer, H.J., Tibolone: A steroid with a tissue-specific mode of action (2001) J Steroid Biochem Mol Biol, 76, pp. 231-238
• Kloosterboer, H.J., Tissue-selectivity: The mechanism of action of tibolone (2004) Maturitas, 48 (1), pp. S30-S40
• Koh, K.K., Horneiii., M.K., Cannoniii., R.O., Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women (1999) Thromb Haemost, 82, pp. 626-633
• Koh, K.K., Han, S.H., Shin, M.-S., Ahn, J.Y., Lee, Y., Shin, E.K., Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: A randomized, double-blind, crossover study (2005) Eur Heart J, 26, pp. 1362-1368
• Koh, K.K., Jeong, A.J., Jin, D.K., Yoon, B.-K., Kim, H.S., Kim, D.S., Kang, W.C., Shin, E.K., Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women (2004) Arterioscler Thromb Vasc Biol, 23, pp. 1889-1894
• Liew, R., Stagg, M.A., MacLeod, K.T., Collins, P., Acute actions of 3-α-hydroxy-tibolone on factors influencing contraction in guinea-pig ventricular myocytes (2004) Eur J Pharmacol, 484, pp. 141-145
• Lloyd, G.W.L., Patel, N.R., McGing, E.A., Cooper, A.F., Kamalvand, K., Jackson, G., Acute effects of hormone replacement with tibolone on myocardial ischaemia in women with angina (1998) Int J Clin Pract, 52, pp. 155-157
• Makkar, R.R., Fromm, B.S., Steinman, R.T., Meissner, M.D., Lehmann, M.H., Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs (1993) JAMA, 270, pp. 2590-2597
• Malinow, M.R., Homocysteine and arterial occlusive diseases (1994) J Intern Med, 236, pp. 603-617
• Mendelsohn, M., Protective effects of estrogen on the cardiovascular system (2002) Am J Cardiol, 89, pp. 12E-18E
• Jhjm, M., Mahm, W., Haverkorn, M.J., Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy (1995) Maturitas, 21, pp. 121-125
• Modelska, K., Cummings, S., Tibolone for postmenopausal women: Systematic review of randomized trials (2002) J Clin Endocrinol Metab, 87, pp. 16-31
• Nathan, L., Chaudhuri, G., Estrogens and atherosclerosis (1997) Annu Rev Pharmacol Toxicol, 37, pp. 477-515
• Palacios, S., Tibolone: A tissue-specific approach to the menopause (2001) Eur Heart J Supplements, 3 (1000), pp. M12-M16
• Pasceri, V., Cheng, J.S., Willerson, J.T., Yeh, E.T., Chang, J., Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs (2001) Circulation, 103, pp. 2531-2534
• Pasceri, V., Willerson, J.T., Yeh, E.T.H., Direct proinflammatory effect of C-reactive protein on human endothelial cells (2000) Circulation, 102, pp. 2165-2168
• Peterson, L.R., Eyster, D., Dávila-Román, V.G., Stephens, A.P., Schechtman, K., Herrero, P., Gropler, R.J., Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women (2001) Am Heart J, 142, pp. 641-647
• Prelevic, G.M., Kwong, P., Byrne, D.J., Jagroop, I.A., Ginsburg, J., Mikhailidis, D.P., A cross-sectional study of effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women (2002) Fertil Steril, 77, pp. 945-951
• Reed, M.J., Kloosterboer, H.J., Tibolone: A selective tissue estrogenic activity regulator (STEAR) (2004) Maturitas, 48 (1), pp. S4-S6
• Reis, S., Gloth, S., Blumenthal, R., Resar, J., Zacur, H., Gerstenblith, G., Brinker, J., Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women (1994) Circulation, 89, pp. 52-60
• Ridker, P.M., Stampfer, M.J., Rifai, N., Novel risk factors for systemic atherosclerosis (2001) JAMA, 285, pp. 2481-2485
• Rossouw, J.E., Anderson, G.L., Prentice, R.L., Lacroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Johnson, K.C., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (2002) JAMA, 288, pp. 321-333. , Writing group for the Women's Health Initiative Investigators (
• Sator, K., Sator, M.O., Sator, P.G., Egarter, C., Huber, J.C., Effects of tibolone on selectins in postmenopausal women (2006) Maturitas, 53, pp. 166-170
• Simoncini, T., Genazzani, A.R., Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells (2000) Mol Cell Endocrinol, 162, pp. 87-94
• Simoncini, T., Mannella, P., Fornari, L., Caruso, A., Varone, G., Garibaldi, S., Genazzani, A.T., Tobolone activates nitric oxide synthesis in human endothelial cells (2004) J Clin Endocrinol Metab, 89, pp. 4594-4600
• Smith, C.L., O'Malley, B.W., Coregulator function: A key to understanding tissue specificity of selective receptor modulators (2004) Endocr Rev, 25, pp. 45-71
• Speroff, L., Clarkson, T.B., Cover Story: Is tibolone a viable alternative to HT? (2003) Contemporary Ob/Gyn, 48, pp. 54-68
• Stamler, J.S., Slivka, A., Biological chemistry of thiols in the vasculature and in vascular-related disease (1996) Nutr Rev, 54, pp. 1-30
• Stampfer, M., Colditz, G., Willett, W., Manson, J., Rosner, B., Speizer, F., Hennekens, C., Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the nurses' health study (1991) N Engl J Med, 325, pp. 756-762
• Taddei, S., Virdis, A., Ghiadoni, L., Mattei, P., Sudano, I., Bernini, G., Pinto, S., Salvetti, A., Menopause is associated with endothelial dysfunction in women (1996) Hypertension, 28, pp. 576-582
• Timmer, C.J., Houwing, N.S., Dose proportionality of three different doses of tibolone (2002) Pharmacotherapy, 22, pp. 6-13
• Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P., Jialal, I., Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells (2002) Circulation, 106, pp. 1439-1441
• Verma, S., Buchanan, M.R., Anderson, T.J., Endothelial function testing as a biomarker of vascular disease (2003) Circulation, 108, pp. 2054-2059
• Von Eckardstein, A., Schmiddem, K., Hovels, A., Gulbahce, E., Schuler-Luttman, S., Elbers, J., Helmond, F., Assmann, G., Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity (2001) Atherosclerosis, 159, pp. 433-439
• Winkler, U.H., Effects of androgens on haemostasis (1996) Maturitas, 24, pp. 147-155
• Winkler, U.H., Altkemper, B., Kwee, B., Helmond, F.A., Coelingh Bennink, H.J., Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: A multicenter, double-blind, randomized study (2000) Fertil Steril, 74, pp. 10-19
• Yang, Y., Loscalzo, J., Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide (2000) Circulation, 101, pp. 2144-2148
• Zandberg, P., Peters, J.L.M., Demacker, P.N.M., Smit, M.J., De Reeder, E.G., Meuleman, D.G., Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits (1998) Arterioscler Thromb Vasc Biol, 18, pp. 1844-1854
• Zoma, W., Baker, R.S., Lang, U., Clark, K.E., Hemodynamic response to tibolone in reproductive and nonreproductive tissues in the sheep (2001) Am J Obstet Gynecol, 184, pp. 554-551
• Zwaka, T.P., Hombach, V., Torzewski, J., C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis (2001) Circulation, 103, pp. 1194-1197

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------